Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenting Wu

Showing results (281-290 of 299) with videos related to

Pageof 30
Sort By:
American Journal of Hematology|April 12, 2014
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cellsClive S Zent, Ronald P Taylor, Margaret A Lindorfer, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Islet-intrinsic sex differences in inflammatory signaling contribute to autoimmune diabetes susceptibilityKierstin L Webster, Armando A Puente, Jacob R Enriquez, et al.
Blood|November 15, 2008
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximabFarrukh T Awan, Neil E Kay, Melanie E Davis, et al.
Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Cell Metabolism|November 18, 2020
Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19Irina Kusmartseva, Wenting Wu, Farooq Syed, et al.
Nature Communications|May 10, 2018
Genome-wide association study in 176,678 Europeans reveals genetic loci for tanning response to sun exposureAlessia Visconti, David L Duffy, Fan Liu, et al.
Nature Communications|February 12, 2020
Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinomaKavita Y Sarin, Yuan Lin, Roxana Daneshjou, et al.
Iucrj|April 14, 2015
Lipidic cubic phase serial millisecond crystallography using synchrotron radiationPrzemyslaw Nogly, Daniel James, Dingjie Wang, et al.
Frontiers in Oncology|January 22, 2025
Initial clinical experience with [<sup>177</sup>Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trialAaron R Hansen, Stephan Probst, Jean-Mathieu Beauregard, et al.
Pageof 30

Showing results (281-290 of 299) with videos related to

Sort By:
Pageof 30
American Journal of Hematology|April 12, 2014
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cellsClive S Zent, Ronald P Taylor, Margaret A Lindorfer, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Islet-intrinsic sex differences in inflammatory signaling contribute to autoimmune diabetes susceptibilityKierstin L Webster, Armando A Puente, Jacob R Enriquez, et al.
Blood|November 15, 2008
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximabFarrukh T Awan, Neil E Kay, Melanie E Davis, et al.
Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Cell Metabolism|November 18, 2020
Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19Irina Kusmartseva, Wenting Wu, Farooq Syed, et al.
Nature Communications|May 10, 2018
Genome-wide association study in 176,678 Europeans reveals genetic loci for tanning response to sun exposureAlessia Visconti, David L Duffy, Fan Liu, et al.
Nature Communications|February 12, 2020
Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinomaKavita Y Sarin, Yuan Lin, Roxana Daneshjou, et al.
Iucrj|April 14, 2015
Lipidic cubic phase serial millisecond crystallography using synchrotron radiationPrzemyslaw Nogly, Daniel James, Dingjie Wang, et al.
Frontiers in Oncology|January 22, 2025
Initial clinical experience with [<sup>177</sup>Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trialAaron R Hansen, Stephan Probst, Jean-Mathieu Beauregard, et al.
Pageof 30